Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1981 Dec 12;283(6306):1561–1562. doi: 10.1136/bmj.283.6306.1561

Prolactinoma: a question of rational treatment.

C R Edwards, C M Feek
PMCID: PMC1508060  PMID: 6796166

Full text

PDF
1561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergh T., Nillius S. J., Wide L. Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors. Br Med J. 1978 Apr 8;1(6117):875–880. doi: 10.1136/bmj.1.6117.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Besser G. M., Parke L., Edwards C. R., Forsyth I. A., McNeilly A. S. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J. 1972 Sep 16;3(5828):669–672. doi: 10.1136/bmj.3.5828.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burrow G. N., Wortzman G., Rewcastle N. B., Holgate R. C., Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med. 1981 Jan 15;304(3):156–158. doi: 10.1056/NEJM198101153040306. [DOI] [PubMed] [Google Scholar]
  4. Child D. F., Gordon H., Mashiter K., Joplin G. F. Pregnancy, prolactin, and pituitary tumours. Br Med J. 1975 Oct 11;4(5988):87–89. doi: 10.1136/bmj.4.5988.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cowden E. A., Ratcliffe J. G., Thomson J. A., Macpherson P., Doyle D., Teasdale G. M. Tests of prolactin secretion in diagnosis of prolactinomas. Lancet. 1979 Jun 2;1(8127):1155–1158. doi: 10.1016/s0140-6736(79)91841-5. [DOI] [PubMed] [Google Scholar]
  6. Cowden E. A., Ratcliffe W. A., Beastall G. H., Ratcliffe J. G. Laboratory assessment of prolactin status. Ann Clin Biochem. 1979 May;16(3):113–121. doi: 10.1177/000456327901600126. [DOI] [PubMed] [Google Scholar]
  7. Franks S., Jacobs H. S., Martin N., Nabarro J. D. Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) 1978 Apr;8(4):277–287. doi: 10.1111/j.1365-2265.1978.tb02770.x. [DOI] [PubMed] [Google Scholar]
  8. Fuxe K., Hökfelt T., Nilsson O. Factors involved in the control of the activity of the tubero-infundibular dopamine neurons during pregnancy and lactation. Neuroendocrinology. 1969;5(5):257–270. doi: 10.1159/000121887. [DOI] [PubMed] [Google Scholar]
  9. Gemzell C., Wang C. F. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril. 1979 Apr;31(4):363–372. doi: 10.1016/s0015-0282(16)43929-4. [DOI] [PubMed] [Google Scholar]
  10. Griffith R. W., Turkalj I., Braun P. Outcome of pregnancy in mothers given bromocriptine. Br J Clin Pharmacol. 1978 Mar;5(3):227–231. doi: 10.1111/j.1365-2125.1978.tb01629.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hall K., McAllister V. L. Metrizamide cisternography in pituitary and juxtapituitary lesions. Radiology. 1980 Jan;134(1):101–108. doi: 10.1148/radiology.134.1.7350588. [DOI] [PubMed] [Google Scholar]
  12. Hardy J. Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg. 1969;16:185–217. doi: 10.1093/neurosurgery/16.cn_suppl_1.185. [DOI] [PubMed] [Google Scholar]
  13. Hwang P., Guyda H., Friesen H. A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1902–1906. doi: 10.1073/pnas.68.8.1902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jacobs H. S., Franks S., Murray M. A., Hull M. G., Steele S. J., Nabarro J. D. Clinical and endocrine features of hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) 1976 Sep;5(5):439–454. doi: 10.1111/j.1365-2265.1976.tb01974.x. [DOI] [PubMed] [Google Scholar]
  15. Jefferson A. Symposium on pituitary tumours. 1. Clinical management and the results of treatment of the chromophobe pituitary adenoma. Clin Radiol. 1966 Apr;17(2):141–148. doi: 10.1016/s0009-9260(66)80077-6. [DOI] [PubMed] [Google Scholar]
  16. Kleinberg D. L., Noel G. L., Frantz A. G. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med. 1977 Mar 17;296(11):589–600. doi: 10.1056/NEJM197703172961103. [DOI] [PubMed] [Google Scholar]
  17. McGregor A. M., Scanlon M. F., Hall K., Cook D. B., Hall R. Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med. 1979 Feb 8;300(6):291–293. doi: 10.1056/NEJM197902083000606. [DOI] [PubMed] [Google Scholar]
  18. McGregor A. M., Scanlon M. F., Hall R., Hall K. Effects of bromocriptine on pituitary tumour size. Br Med J. 1979 Sep 22;2(6192):700–703. doi: 10.1136/bmj.2.6192.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Quigley M. E., Judd S. J., Gilliland G. B., Yen S. S. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab. 1979 Apr;48(4):718–720. doi: 10.1210/jcem-48-4-718. [DOI] [PubMed] [Google Scholar]
  20. Quigley M. E., Judd S. J., Gilliland G. B., Yen S. S. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma. J Clin Endocrinol Metab. 1980 Jun;50(6):994–998. doi: 10.1210/jcem-50-6-994. [DOI] [PubMed] [Google Scholar]
  21. Scanlon M. F., Rodriguez-Arnao M. D., McGregor A. M., Weightman D., Lewis M., Cook D. B., Gomez-Pan A., Hall R. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clin Endocrinol (Oxf) 1981 Feb;14(2):133–143. doi: 10.1111/j.1365-2265.1981.tb00608.x. [DOI] [PubMed] [Google Scholar]
  22. Teasdale G. M., Ratcliffe J. G., Thomson J. A., Cowden E. A. The prolactinoma problem. Lancet. 1980 Apr 26;1(8174):925–926. [PubMed] [Google Scholar]
  23. Thorner M. O., Edwards C. R., Charlesworth M., Dacie J. E., Moult P. J., Rees L. H., Jones A. E., Besser G. M. Pregnancy in patients presenting with hyperprolactinaemia. Br Med J. 1979 Sep 29;2(6193):771–774. doi: 10.1136/bmj.2.6193.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Thorner M. O., Martin W. H., Rogol A. D., Morris J. L., Perryman R. L., Conway B. P., Howards S. S., Wolfman M. G., MacLeod R. M. Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab. 1980 Sep;51(3):438–445. doi: 10.1210/jcem-51-3-438. [DOI] [PubMed] [Google Scholar]
  25. Tucker H. S., Grubb S. R., Wigand J. P., Taylon A., Lankford H. V., Blackard W. G., Becker D. P. Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal. Ann Intern Med. 1981 Mar;94(3):302–307. doi: 10.7326/0003-4819-94-3-302. [DOI] [PubMed] [Google Scholar]
  26. WHITE J. C., BALLANTINE H. T., Jr Intrasellar aneurysms simulating hypophyseal tumours. J Neurosurg. 1961 Jan;18:34–50. doi: 10.3171/jns.1961.18.1.0034. [DOI] [PubMed] [Google Scholar]
  27. Wass J. A., Moult P. J., Thorner M. O., Dacie J. E., Charlesworth M., Jones A. E., Besser G. M. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet. 1979 Jul 14;2(8133):66–69. doi: 10.1016/s0140-6736(79)90120-x. [DOI] [PubMed] [Google Scholar]
  28. White M. C., Anapliotou M., Rosenstock J., Mashiter K., Joplin G. F. Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas. Lancet. 1981 Jun 27;1(8235):1394–1396. doi: 10.1016/s0140-6736(81)92571-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES